| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 10.025 | 10.469 | 4.006 | 4.796 | 11.916 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 10.067 | 10.851 | 4.163 | 5.484 | 12.476 | 430 | 1.237 | 0 | 0 |
| Total Expenses - EUR | - | 1.544 | 5.988 | 2.667 | 77.034 | 61.037 | 15.077 | 12.050 | 3.689 | 10.279 |
| Gross Profit/Loss - EUR | - | 8.524 | 4.862 | 1.496 | -71.550 | -48.561 | -14.648 | -10.813 | -3.689 | -10.279 |
| Net Profit/Loss - EUR | - | 8.223 | 4.540 | 1.376 | -71.645 | -48.884 | -14.648 | -10.813 | -3.689 | -10.279 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Europharmedtech Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 701 | 0 | 0 | 61.484 | 53.581 | 45.806 | 39.507 | 39.254 | 38.890 |
| Current Assets | - | 9.252 | 14.442 | 15.541 | 43.594 | 18.247 | 15.548 | 15.856 | 16.590 | 16.287 |
| Inventories | - | 0 | 0 | 0 | 22.419 | 14.726 | 14.400 | 14.531 | 14.487 | 14.406 |
| Receivables | - | 59 | 2.886 | 0 | 8.902 | 2.526 | 981 | 1.325 | 1.563 | 1.727 |
| Cash | - | 9.193 | 11.557 | 15.541 | 12.274 | 995 | 167 | 0 | 540 | 153 |
| Shareholders Funds | - | 9.559 | 13.937 | 15.057 | -56.880 | -104.686 | -117.013 | -128.189 | -131.490 | -141.034 |
| Social Capital | - | 1.336 | 1.313 | 1.289 | 1.264 | 1.240 | 1.213 | 1.217 | 1.213 | 1.206 |
| Debts | - | 394 | 505 | 485 | 162.078 | 176.515 | 178.367 | 183.552 | 187.333 | 196.210 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7499 - 7499" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Europharmedtech Srl